期刊档案 · 医学-血液学
Vox Sanguinis
ISSN 0042-9007 · eISSN 1423-0410 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · 创刊 1953
Vox Sanguinis 中科院 医学 4区（2025 年升级版），影响因子 1.53，混合开放获取，APC 约 4,150 美元，近 24 个月 105 篇文章投稿到接收中位 96 天，录用比例较易（社区反馈），2025 年发文 214 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Vox Sanguinis 由 Wiley-Blackwell Publishing Ltd 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Blood groups and transfusion、Blood transfusion and management、Erythrocyte Function and Pathophysiology 等主题的论文，这 3 个主题约占 39.7%。（根据 OpenAlex 主题统计与中科院分区数据生成）
Vox Sanguinis is an international journal published on behalf of the International Society of Blood Transfusion (ISBT), reporting on significant developments and advancements in transfusion medicine.Aims and ScopeVox Sanguinis reports on all issues related to transfusion medicine, ‘vein to vein’ from donor to recipient, and including cellular therapies. Comments, reviews, original articles, short reports and international fora are published, grouped into eight main sections: 1) Donors and Donations Donor recruitment and retention Donor selection Donor health (vigilance, side effects of donation) Big data analysis and blood donation 2) Blood Component Collection and Production Blood collection methods and devices (including apheresis) Blood component preparation and storage Inventory management Collection and storage of cells for cell therapies Quality management and good manufacturing practice Automation and information technology Plasma fractionation techniques and plasma derivatives 3) Transfusion-transmitted Disease and its Prevention Identification and epidemiology of infectious pathogens transmissible by blood Donor testing for transfusion-transmissible infectious pathogens Bacterial contamination of blood components Pathogen inactivation 4) Transfusion Medicine and New Therapies Transfusion practice, thresholds and audits Transfusion efficacy assessment, clinical trials Non-infectious transfusion adverse events Therapeutic apheresis 5) Haemovigilance Near misses, adverse events and side effects throughout the transfusion chain Monitoring, reporting and analysis of those adverse events and side effects Activities aiming at increasing the safety of the whole transfusion chain Standardization of the definition of adverse events and side effects 6) Patient Blood Management Caring for patients who might need a transfusion Transfusion indication decision-making process Search for the optimal patient outcomes Study of transfusion alternatives Autologous blood transfusion 7) Immunohaematology Red cell, platelet and granulocyte immunohaematology Blood phenotyping and genotyping Molecular genetics of blood groups Alloimmunity of blood Pre-transfusion testing Autoimmunity in transfusion medicine Blood typing reagents and technology Immunogenetics of blood cells and serum proteins: polymorphisms and function Complement in immunohaematology Parentage testing and forensic immunohaematology 8) Cellular Therapies Cellular therapy (sources; products; processing and s
摘自期刊官网 Aims & Scope
研究方向（LetPub）：医学-血液学
主编 Miquel Lozano出版商官网
编委会国家分布：未见中国大陆编委；主要国家 美国 2、日本 1、法国 1、西班牙 1、加拿大 1（共 11 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Blood groups and transfusionMedicine20.8%
- Blood transfusion and managementMedicine10.1%
- Erythrocyte Function and PathophysiologyMedicine8.7%
- Blood donation and transfusion practicesBusiness, Management and Accounting8.2%
- Platelet Disorders and TreatmentsMedicine5.7%
- Hepatitis B Virus StudiesMedicine4.5%
- Hemoglobinopathies and Related DisordersMedicine3.9%
- Blood disorders and treatmentsBiochemistry, Genetics and Molecular Biology3.7%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 4 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent Contents出版商官网
其他：EBSCO、ProQuest、AGRICOLA
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 1.53LetPub ·
- 影响因子（出版商公布） 2025
- 1.6出版商官网 ·
- CiteScore 2026-06
- 3.2LetPub ·
- CiteScore（出版商公布） 2025
- 3.2出版商官网 ·
- SJR 2026-06
- 0.59LetPub ·
- SNIP 2026-06
- 1.04LetPub ·
- h-index
- 77LetPub ·
- h-index
- 130OpenAlex ·
- i10-index
- 4,752OpenAlex ·
- 两年平均被引
- 1.54OpenAlex ·
- 自引率
- 18.8%LetPub ·
- Gold OA 文章占比
- 40.47%LetPub ·
发文规模
- 年文章数
- 147LetPub ·
- 年发文量（出版商公布） 2025
- 168出版商官网 ·
- 年下载量（出版商公布） 2025
- 446,637出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 16,595 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 223 | 154 | 74 |
| 2025 | 214 | 120 | 311 |
| 2024 | 209 | 138 | 611 |
| 2023 | 197 | 127 | 714 |
| 2022 | 175 | 55 | 968 |
| 2021 | 194 | 80 | 1,580 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
96 天投稿到接收中位数 · P25–P75 62 天 – 141 天
- 接收到上线
- 中位数 18 天（105 篇）
- 投稿到上线
- 中位数 115 天
- 样本
- 105 篇有投稿与接收日期的文章（窗口内共 425 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 较慢,6-12周LetPub ·
- 平均录用比例（社区反馈）
- 较易LetPub ·
- 录用率（出版商公布） 2025
- 40%出版商官网 ·
- 投稿到首次决定 2025
- 26 天出版商官网 ·
- 投稿到接收 2025
- 92 天出版商官网 ·
- 接收到发表 2025
- 22 天出版商官网 ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / EUR 3,470 / GBP 2,780 | — | — | |
| 出版商官网 | 有，金额未公布 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点7 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- 3–6 个
- 正文篇幅
- ≤ 5,000 词
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 首次投稿格式
- 允许不按期刊格式排版（free format）
- Highlights（研究亮点）
- 必须提供
- 投稿信（Cover letter）
- 必须提供
接收的文章类型13 种，含篇幅限制
- case reportOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…未说明篇幅
- case reportsThe submission of Case Reports is not encouraged.未说明篇幅
- commentaryOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…未说明篇幅
- international forumPeriodically, Vox Sanguinis publishes an International Forum (IF) to examine the management of a topic in different jurisdictions.未说明篇幅
- letterOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…未说明篇幅
- letters to the editorLetters to the Editor are welcome but should contain no more than 800 words and a maximum of 10 references.未说明篇幅
- obituariesObituaries should not exceed 600 words (excluding authors names and affiliations) and should be accompanied by a headshot of the person, with the aim being to p…未说明篇幅
- original articleOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…正文 ≤ 5,000 词
- original articlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (including the title page,…未说明篇幅
- reportsReports should be a maximum of approximately 6,600 words and should include an abstract (200 words), which need not be structured.未说明篇幅
- reviewOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…未说明篇幅
- reviewsReview articles are published on subjects of interest to the broad readership of the journal. Articles should not exceed 6,600 words (including the title page, …未说明篇幅
- short reportShort reports should be a maximum of 2,500 words including the abstract, main text, references, figure legends and tables, but excluding the author names and af…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、同行评审、查重、自存档
- AI 使用 Artificial Intelligence Generated Content
Artificial Intelligence Generated Content (AIGC) tools — such as ChatGPT and others based on large language models (LLMs) — cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for a research design, which is a generally held requirement of authorship, nor do they have legal standing or …
原文 ↗出版商官网 ·- 作者资格 Authorship
On initial submission, the submitting author will be prompted to provide the email address and country for all contributing authors.
原文 ↗出版商官网 ·- 利益冲突 Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section "Conflict of Interest" in the Editorial Policies and Ethical Considerations' section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
原文 ↗出版商官网 ·- 数据可用性 Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
原文 ↗出版商官网 ·- 出版伦理 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and Acceptance The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. The journal operates a st…
原文 ↗出版商官网 ·- 许可与版权
Standard copyright or open access under Creative Commons License. 模型摘要
Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access under the terms of a Creative Commons License.
原文 ↗出版商官网 ·- 同行评审 Peer Review and Acceptance
Single-blind peer review. 模型摘要
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
原文 ↗出版商官网 ·- 查重
Uses iThenticate CrossCheck for plagiarism detection. 模型摘要
Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
原文 ↗出版商官网 ·- 自存档
Self-archiving allowed under specific conditions. 模型摘要
Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Wiley-Blackwell Publishing Ltd
- 出版国家或地区
- ENGLAND
- 出版语言
- English
- 出版周期
- Bimonthly
- 创刊年份
- 1953
- ISSN
- 0042-9007
- 电子版 ISSN
- 1423-0410
- 学会 / 主办单位
- International Society of Blood Transfusion
常见问题
关于 Vox Sanguinis 的常见问题
Vox Sanguinis 是中科院几区期刊？
2025 年升级版分区表中，Vox Sanguinis 为医学 4区，小类 血液学 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Vox Sanguinis 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 1.53，CiteScore 为 3.2，h-index 为 130。
Vox Sanguinis 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）105 篇已发表文章登记的日期，投稿到接收的中位数为 96 天（四分位 62–141 天）；投稿社区反馈的平均审稿速度为6–12 周，平均录用比例反馈为“较易”；期刊官网公布的录用率为 40%（2025）。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Vox Sanguinis 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：3–6 个；正文篇幅：≤ 5,000 词；参考文献格式：顺序编码制（按引用顺序编号）；首次投稿格式：允许不按期刊格式排版（free format）；Highlights：必须提供；投稿信：必须提供。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Vox Sanguinis 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 11 位编委中，没有中国大陆学者；人数最多的国家是 美国（2 位）、日本（1 位）、法国（1 位）。统计按编委会页面列出的机构国家计，仅供参考。
Vox Sanguinis 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Vox Sanguinis 被 SCIE、Scopus 收录。期刊官网自述还被 MEDLINE、PubMed、Embase、CAS、CAB Abstracts、Current Contents 收录，该清单未与各数据库逐一核对。
Vox Sanguinis 是开放获取期刊吗？版面费多少？
Vox Sanguinis 为混合开放获取。选择开放获取发表时APC 约 4,150 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。